Metabolic pathways, genomics and inflammation in cardiovascular disease, including CHIP mechanisms and therapeutic targets[9]

Jessica Ann Regan
Cardiology Fellowship at Duke University, School of Medicine
As of 2025 · Last known relationship

Cardiology Fellowship at Duke University, School of Medicine
As of 2025 · Last known relationship
Became interested in genetics in cardiovascular disease as an undergraduate sophomore at the University of Arizona while studying sarcomeric mutations
Conducted Duke R38 research with mentor Svati Shah in collaboration with Dawn Bowles
Jessica Ann Regan is a Duke cardiologist and cardiovascular researcher whose work connects clonal hematopoiesis of indeterminate potential with cardiometabolic disease, cardiorespiratory fitness, and cardiovascular outcomes. She is an Assistant Professor of Medicine in Cardiology at Duke University. She completed Duke internal medicine residency from 2017 to 2021, served as chief resident in 2021-2022, and completed cardiology fellowship in 2022-2025. She earned an M.D. from Virginia Commonwealth University in 2017 and a B.S. from the University of Arizona in 2012. Her research examines metabolic pathways, genomics, and inflammation, including CHIP mechanisms and therapeutic targets. She also participated in Duke's R38 Resident Research Pathway and was selected as the 2020 Mandel Fellow.
Each topic is linked to its supporting source in Sources.
Training includes Cardiology Fellowship at Duke University, School of Medicine, Co-presented Medicine Grand Rounds on Clonal Hematopoiesis of Indeterminate Potential: Spanning Pre-Malignant, Malignant and Cardiovascular Disease with Bennett Caughey, Internal Medicine Chief Resident, and Internal Medicine Residency at Duke University, School of Medicine, plus 5 more records.
Explore education and training2029
2029
As of 2025
As of 2023
As of 2022
As of 2021
2020
As of 2012
Completed 2017
Metabolic pathways, genomics and inflammation in cardiovascular disease, including CHIP mechanisms and therapeutic targets[9]
Studying associations between clonal hematopoiesis of indeterminate potential and cardiorespiratory fitness in the STRRIDE and HF-ACTION cohorts[8]